Skip to content

Clinical trials

Pneumonia trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pneumonia Country / region: France Clear all

121 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20044
20053
20063
20072
20094
20101
20111
20123
20133
20142
20153
20167
201710
20189
20197
202027
20217
20225
20232
20246
20257
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed73
Unknown status18
Terminated15
Recruiting8
Not yet recruiting3
Active, not recruiting2
No longer available1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris17
Hospices Civils de Lyon7
Nantes University Hospital7
University Hospital, Toulouse5
Bayer4
University Hospital, Montpellier4
Aridis Pharmaceuticals, Inc.3
Assistance Publique Hopitaux De Marseille3
Association Clinique Thérapeutique Infantile du val de Marne3
CHU de Reims3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pneumonia121
COVID-1925
Pneumonia, Ventilator-Associated15
Community-Acquired Pneumonia11
Respiratory Distress Syndrome10
Coronavirus Infections7
Bronchiolitis6
Pneumonia, Bacterial6
Pneumonia, Viral6
Pseudomonas Infections6

Trials

Showing 51 to 75 of 121. Each trial links to its page on Pharma Observatory.

21 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.